• Novozymes completed the acquisition of Australia-based MicroBioGen on Oct. 1, 2026, following receipt of required regulatory clearances.
• Deal lifts Novozymes’ prior 23% stake to full ownership, extending a partnership and investment relationship that began in 2013.
• MicroBioGen adds yeast-breeding and strain-development capabilities, with a track record in bioethanol and potential uses across other industrial markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novozymes A/S published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.